EP Biocomposites last traded at ₹92.00 (2026-10-13). Over the past month the stock moved -13.1%, three months the stock moved -5.8%, year the stock moved -30.8%. Its closing range over 52 weeks is ₹86.60 – ₹136.00, with the latest close 32.4% below the high.
Closing prices up to 2026-10-13.
Incorporated in 2020, EP Biocomposites Ltd manufactures fibre reinforced polymer products and provides bio toilet solutions[1]
Business Overview:[1] a) EPBL is a flagship entity of EP Kamat Group. b) It manufactures and supplies Fibre Reinforced Polymers (FRP) products such as Door Shutters, Frames, Laminated Doors, Biodigester Tanks, Bio Toilets and Allied Products for Construction and Industrial applications c) Company has an Aqua Division which offers Sewage & Effluent Treatment Plants for Hotels, Industry, Institutions, Government bodies as well as residential and commercial buildings d) In FY24, company has added the line of Fire doors to its portfolio
In the latest quarter (Mar 2026), EP Biocomposites reported sales of ₹9.57 crore (+35.9%) and net profit of ₹1.37 crore (+47.3%), compared with the same quarter last year.
| Period | Sales | Operating profit | OPM % | Net profit | EPS (₹) |
|---|---|---|---|---|---|
| Mar 2026 | 9.57 | 1.99 | 20.79 | 1.37 | 8.15 |
| Sep 2025 | 4.07 | 0.25 | 6.14 | 0.09 | 0.54 |
| Mar 2025 | 7.60 | 1.29 | 16.97 | 0.83 | 4.94 |
| Sep 2024 | 4.40 | 0.49 | 11.14 | 0.21 | 1.25 |
| Mar 2024 | 7.04 | 1.14 | 16.19 | 0.93 | 5.53 |
| Sep 2023 | 4.40 | 0.26 | 5.91 | 0.22 | 1.31 |
| Mar 2023 | 3.68 | 0.42 | 11.41 | 0.30 | 1.78 |
| Sep 2022 | 3.45 | 0.53 | 15.36 | 0.27 | 1.61 |
| Sep 2023 | Mar 2024 | Sep 2024 | Mar 2025 | Sep 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|
| Sales growth | +59.4% | +32.8% | +27.5% | +106.5% | -7.5% | +35.9% |
| Operating profit growth | -23.5% | +10.7% | -7.5% | +207.1% | -3.8% | +74.6% |
| Net profit growth | -8.3% | +63.2% | -22.2% | +176.7% | -59.1% | +47.3% |
| EPS growth | -35.8% | +14.3% | -22.4% | +177.5% | -58.8% | +47.4% |
| OPM % | 5.9% | 16.2% | 11.1% | 17.0% | 6.1% | 20.8% |
Colour scale: below -5% -5% to 0% 0% to 5% 5% to 20% 20% and above. A dash means the earlier figure was zero or negative, so a percentage is not meaningful.
In the latest year (Mar 2026), EP Biocomposites reported sales of ₹13.64 crore (+13.6%) and net profit of ₹1.46 crore (+41.7%), compared with the previous year.
| Period | Sales | Operating profit | OPM % | Net profit | EPS (₹) |
|---|---|---|---|---|---|
| Mar 2026 | 13.64 | 2.24 | 16.42 | 1.46 | 8.68 |
| Mar 2025 | 12.01 | 1.77 | 14.74 | 1.03 | 6.13 |
| Mar 2024 | 11.43 | 1.41 | 12.34 | 1.15 | 6.84 |
| Mar 2023 | 7.12 | 0.97 | 13.62 | 0.58 | 3.45 |
| Mar 2022 | 8.06 | 1.40 | 17.37 | 0.81 | 6.88 |
| Mar 2021 | 2.95 | 0.46 | 15.59 | 0.36 | 72.00 |
| Mar 2020 3m | 0.57 | 0.04 | 7.02 | 0.03 | 6.00 |
| Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|
| Sales growth | +417.5% | +173.2% | -11.7% | +60.5% | +5.1% | +13.6% |
| Operating profit growth | +1050.0% | +204.3% | -30.7% | +45.4% | +25.5% | +26.6% |
| Net profit growth | +1100.0% | +125.0% | -28.4% | +98.3% | -10.4% | +41.7% |
| EPS growth | +1100.0% | -90.4% | -49.9% | +98.3% | -10.4% | +41.6% |
| OPM % | 15.6% | 17.4% | 13.6% | 12.3% | 14.7% | 16.4% |
Colour scale: below -5% -5% to 0% 0% to 5% 5% to 20% 20% and above. A dash means the earlier figure was zero or negative, so a percentage is not meaningful.
No AI analysis generated yet for EP Biocomposites.
Get Free AI Stock Analysis FREE →No recent news available for EP Biocomposites.
EP Biocomposites shares were last quoted at ₹92.00 (+0.0% on the day). Use the Refresh price button on this page for the latest available price. Prices are for information only.
EP Biocomposites has a price-to-earnings (P/E) ratio of 11.32 and a price-to-book (P/B) ratio of 1.37. The industry P/E is 39.43.
The 52-week high of EP Biocomposites is ₹149.90 and the 52-week low is ₹75.50.
The market capitalisation of EP Biocomposites is about ₹16.51 crore.
In the latest quarter (Mar 2026), EP Biocomposites reported sales of ₹9.57 crore (+35.9%) and net profit of ₹1.37 crore (+47.3%), compared with the same quarter last year.
This page is for information and is not investment advice. As per the data shown here, EP Biocomposites has a 3-year ROE of 12.00%, 3-year profit growth of 36.00%. Review the fundamentals, quarterly results and AI analysis on StockSpin, and consult a SEBI-registered adviser before investing.
Promoters hold about 70.08% of EP Biocomposites.
EP Biocomposites belongs to the Plastic Products - Others sector.
All Plastic Products - Others stocks · Browse all stocks A–Z